Xacduro is a co-packaged product containing sulbactam, a beta-lactam antibiotic and beta-lactamase inhibitor, with durlobactam, a beta-lactamase inhibitor, that is approved for use in patients 18 years of age and older for the management of hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP) caused by susceptible strains of Acinetobacter species.
Sulbactam/durlobactam only has activity against Acinetobacter species and should NOT be used to treat HAP/VAP caused by other bacteria.
There's more to see -- the rest of this topic is available only to subscribers.